SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anlon Healthcare Ltd (AHCL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544497 NSE: AHCL Pharmaceuticals & Drugs | Small Cap | Anlon Healthcare Share Price

₹14.17 0.44 (3.20%)

As on 04-Jun'26 16:59

Anlon Healthcare Ltd (AHCL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544497 NSE: AHCL Pharmaceuticals & Drugs | Small Cap | Anlon Healthcare Share Price

₹14.17 0.44 (3.20%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹753 Cr.
Current Price
₹14.2
52-Week Low / High
₹9 / 17
TTM EPS
₹0.5
TTM Sales
₹177 Cr.
Book Value per Share
₹5
P/E Ratio
27.08
Lower than its 5-year historical median
Industry PE
46.5
Price to Book (P/B)
2.86
Lower than its 5-year historical median
Price to Sales (P/S)
4.27
Lower than its 5-year historical median
EV/EBITDA
17.14
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
40.45%
Outperforms industry median
Return on Capital Employed (ROCE)
24.83%
Outperforms industry median
Return on Assets (ROA)
13.27%
Operating Profit Margin
27.2%
Net Profit Margin
17.06%
Gross Profit Margin
23.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
80.67%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
107.19%
Net Profit Growth (1 Year)
-
112.42%
Asset Quality
Promoter Holding
52.68%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹157 Cr.
Equity
₹106.3 Cr.
Face Value
₹2
All Time Low / High
₹8.70 / 17.20

Anlon Healthcare stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Fair

Price Trend

Weak
Q.1 Is Anlon Healthcare Ltd a good quality company?
Anlon Healthcare Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Anlon Healthcare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Anlon Healthcare Ltd vs industry peers?
Anlon Healthcare Ltd revenue CAGR is 28.16%, compared to the industry median CAGR of 6.81%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Anlon Healthcare Ltd?
Promoters hold 52.68% of the Anlon Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Anlon Healthcare Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Anlon Healthcare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 6.4%15.4%15.5%24.8%-
Value Creation
Index
-0.50.10.10.8-

Growth Parameters

Sales 57.111366.6120177
Sales YoY Gr.-97.6%-41%80.7%-
Adj EPS -00.50.60.50.5
YoY Gr.-NA19.6%-14.8%-
BVPS (₹) 0.10.61.325
Adj Net
Profit
-0.16.19.720.628
Cash Flow from Ops. -1.8-2.9-3.2-22.6-
Debt/CF from Ops. -35.6-24.7-25.2-3-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA28.2%80.7%
Adj EPS NANANA-14.8%
BVPSNANA149.5%54.2%
Share Price - - - -

Key Financial Parameters

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-6.6136.468.240.614.9
Op. Profit
Mgn %
9.711.523.627.226.2
Net Profit
Mgn %
-0.25.414.517.115.7
Debt to
Equity
40.19.53.90.80
Working Cap
Days
0219490385348
Cash Conv.
Cycle
0109283226231

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales5711367120
Operating Expenses + 521005188
Manufacturing Costs3574
Material Costs43883475
Employee Cost 3455
Other Costs 2355
Operating Profit 6131633
Operating Profit Margin (%) 9.7%11.1%23.6%27.1%
Other Income + 0000
Exceptional Items 0000
Interest 4444
Depreciation 2222
Profit Before Tax -071027
Tax 0106
Profit After Tax -061021
PAT Margin (%) -0.2%5.2%14.5%17.1%
Adjusted EPS (₹)-0.00.50.60.5
Dividend Payout Ratio (%)0%0%0%0%

Valuation of Anlon Healthcare - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 272180
Share Capital 12121640
Reserves -10-5541
Debt +60667558
Long Term Debt52585438
Short Term Debt882020
Minority Interest0000
Trade Payables15252020
Others Liabilities 8121223
Total Liabilities 85112128181

Fixed Assets

Net Fixed Assets +27262723
Gross Block35353836
Accumulated Depreciation791113
CWIP 0000
Investments 2411
Inventories27274250
Trade Receivables20443975
Cash Equivalents 2121
Others Assets 7111731
Total Assets 85112128181

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -2-3-3-23
PBT -071027
Adjustment 6666
Changes in Working Capital -8-15-19-54
Tax Paid 00-0-1
Cash Flow From Investing Activity + -0-0-33
Capex -0-0-33
Net Investments 0000
Others 0000
Cash Flow From Financing Activity + 32819
Net Proceeds from Shares 00439
Net Proceeds from Borrowing 166-4-16
Interest Paid -4-4-4-4
Dividend Paid 0000
Others -9012-0
Net Cash Flow 1-12-1

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-6.93130.3767.9940.45
ROCE (%)6.4215.4215.4824.83
Asset Turnover Ratio0.671.150.560.78
PAT to CFO Conversion(x)N/A-0.5-0.3-1.1
Working Capital Days
Receivable Days129.70103.70226.20172.60
Inventory Days170.5086.80188.20139.60
Payable Days128.3084.20245.7097

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Anlon Healthcare Ltd FAQs

The current trading price of Anlon Healthcare on 04-Jun-2026 16:59 is ₹14.17.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Anlon Healthcare stood at ₹753.2 Cr

The latest P/E ratio of Anlon Healthcare as of 03-Jun-2026 is 27.08.

The latest P/B ratio of Anlon Healthcare as of 03-Jun-2026 is 2.86.

The 52-week high of Anlon Healthcare is ₹17.20 and the 52-week low is ₹8.70.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Anlon Healthcare is ₹177 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Anlon Healthcare Ltd is a below average quality company.

The key valuation ratios of Anlon Healthcare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Anlon Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Anlon Healthcare Ltd

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×